Tom Brady opens up about his health amid GLP-1 surge: Water, movement and discipline
Seven-time Super Bowl champ Tom Brady says he wants to break the stigma around willpower as he joins eMed's mission to bring GLP-1 weight-loss support to workers.
90,000 bottles of children's ibuprofen recalled nationwide, FDA says
The FDA has recalled nearly 90,000 bottles of children's ibuprofen after complaints of a gel-like mass and black particles in the product.
Costco enters fertility care with massive discounts for members through new healthcare partnerships
Costco enters fertility care with massive discounts on IVF, egg freezing and medications through new partnership with Sesame and IVI RMA North America.
Herbal supplement found to contain hidden Viagra ingredient, FDA urges consumers to stop use
An herbal supplement recall was issued after the product was found to contain undisclosed Viagra ingredient sildenafil, posing potential health risks for users.
Two major drug companies are the latest to join TrumpRx
President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut costs associated with prescription drugs.
Egg prices plunge as avian flu impact eases, but risks remain
Egg prices plummet 42% in one year as avian flu outbreak subsides, but experts warn new detections could spark fresh volatility in coming months.
TrumpRx aims to slash prescription drug prices
Fox News senior medical analyst Dr. Marc Siegel has the latest on the discounted products under President Donald Trump's plan on 'The Bottom Line.'
House Republicans expand Medicaid fraud probe to ten states
'The Big Money Show' panel discusses the crackdown on Medicaid fraud as the House expands its probe to ten states.
Trump's actions against Iran were 'lawful' and 'righteous,' Rep. Lawler argues
New York Congressman Mike Lawler defends President Trump's actions against Iran amid Democrat opposition, the House vote on the war powers resolution and the probe into New York's Medicaid program on 'Varney & Co.'
Dr. Oz launches fraud probe into New York's bloated Medicaid program
'The Big Money Show' discusses the crackdown on state healthcare fraud as CMS administrator Dr. Mehmet OZ launches a probe into New York's Medicaid program.
Novo Nordisk to slash list prices of Ozempic, Wegovy by up to 50%
Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, lowering costs to $675 per dose.
Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility
Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over 500 manufacturing jobs plus 4,000 construction jobs.
Trump-era FDA clears path for Moderna flu vaccine review after regulatory standoff
Moderna President Dr. Stephen Hoge joins ‘Mornings with Maria’ to discuss the FDA’s decision to review the company’s mRNA flu vaccine, new cancer vaccine breakthroughs and what’s next for growth in the US and abroad.
Cheerios maker says cost of living, housing expenses changing way consumers spend
General Mills trimmed its full-year forecast as consumers rethink grocery spending, seek better-for-you foods and slow purchases of traditional packaged brands.
Dagen McDowell: AI, nation need to deal with exploding health care cost in order to continue existing
'The Big Money Show' panel analyzes the 'gray-shaped economy' and the January jobs report.
Amazon Pharmacy to expand same-day prescription delivery to 4,500 US cities
Amazon plans to expand same-day prescription delivery to nearly 4,500 US cities by 2026, adding 2,000 communities and expanding savings programs.
FDA eyes ban on BHA preservative found in 4,600 foods amid cancer concerns, commissioner says
FDA Commissioner Dr. Marty Makary joins ‘Varney & Co.’ to discuss the agency’s review of cancer-linked food additives, rising teen THC vaping and concerns over Moderna’s mRNA flu shot trial.
Novo CEO outlines long-term strategy amid Trump-era drug talks: ‘We’re here to stay’
Novo Nordisk President and CEO Mike Doustdar joins ‘Mornings with Maria’ to discuss the launch of the first GLP-1 weight-loss pill in the U.S., the lawsuit against Hims & Hers and talks with the Trump administration on drug pricing.
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight-loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Trump announces launch of discount drug website: TrumpRx.gov
'The Big Money Show' discusses President Donald Trump's announcement of the TrumpRx.gov website and his efforts to lower prescription costs.